Fidia Farmaceutici Continues On Its Growth Path: Fidia Signed A Binding Agreement With Sanofi For The Acquisition Of A Portfolio Of Anti-inflammatory Drugs
The operation confirms the pharmaceutical company’s path to internationalisation and the plan to increase its range of therapeutic options by accessing different strategic sectors, thereby strengthening its presence on the prescription drug market. Fidia, a multinational pharmaceutical company and world leader in the research, development, production, and marketing of products mainly based on hyaluronic acid and […]
